7-140734774-CAAAAAA-CAAAAAAA

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_004333.6(BRAF):​c.2128-5dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 676,340 control chromosomes in the GnomAD database, including 424 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.25 ( 194 hom., cov: 27)
Exomes 𝑓: 0.15 ( 230 hom. )

Consequence

BRAF
NM_004333.6 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:9O:1

Conservation

PhyloP100: 1.19

Publications

3 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 7-140734774-C-CA is Benign according to our data. Variant chr7-140734774-C-CA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 44820.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.2248-5dupT
splice_region intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.2128-5dupT
splice_region intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.2248-5dupT
splice_region intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.2248-5_2248-4insT
splice_region intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.2128-5_2128-4insT
splice_region intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.2248-5_2248-4insT
splice_region intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
5920
AN:
24098
Hom.:
193
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.118
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.250
Gnomad SAS
AF:
0.265
Gnomad FIN
AF:
0.198
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.303
Gnomad OTH
AF:
0.224
GnomAD4 exome
AF:
0.146
AC:
95463
AN:
652242
Hom.:
230
Cov.:
28
AF XY:
0.146
AC XY:
47957
AN XY:
328656
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0631
AC:
937
AN:
14852
American (AMR)
AF:
0.0962
AC:
1357
AN:
14112
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
1679
AN:
11272
East Asian (EAS)
AF:
0.146
AC:
2846
AN:
19492
South Asian (SAS)
AF:
0.163
AC:
5238
AN:
32058
European-Finnish (FIN)
AF:
0.152
AC:
3269
AN:
21496
Middle Eastern (MID)
AF:
0.135
AC:
324
AN:
2394
European-Non Finnish (NFE)
AF:
0.149
AC:
75702
AN:
509494
Other (OTH)
AF:
0.152
AC:
4111
AN:
27072
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.335
Heterozygous variant carriers
0
6629
13258
19888
26517
33146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2562
5124
7686
10248
12810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
5915
AN:
24098
Hom.:
194
Cov.:
27
AF XY:
0.238
AC XY:
2684
AN XY:
11266
show subpopulations
African (AFR)
AF:
0.117
AC:
629
AN:
5360
American (AMR)
AF:
0.214
AC:
393
AN:
1834
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
215
AN:
714
East Asian (EAS)
AF:
0.253
AC:
225
AN:
890
South Asian (SAS)
AF:
0.265
AC:
234
AN:
882
European-Finnish (FIN)
AF:
0.198
AC:
227
AN:
1146
Middle Eastern (MID)
AF:
0.385
AC:
20
AN:
52
European-Non Finnish (NFE)
AF:
0.303
AC:
3887
AN:
12818
Other (OTH)
AF:
0.216
AC:
64
AN:
296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
192
384
576
768
960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (6)
-
-
2
not provided (2)
-
1
-
Cardio-facio-cutaneous syndrome (1)
-
1
-
Congenital long QT syndrome (1)
-
1
-
Noonan syndrome (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)
-
1
-
Noonan syndrome with multiple lentigines (1)
-
-
1
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373442098; hg19: chr7-140434574; COSMIC: COSV56184569; API